These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8905327

  • 21. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
    Braida D, Sala M.
    Neuroreport; 2000 Jun 26; 11(9):2025-9. PubMed ID: 10884065
    [Abstract] [Full Text] [Related]

  • 22. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH, Martin BR.
    Pharmacol Biochem Behav; 1997 Jun 26; 57(1-2):7-12. PubMed ID: 9164547
    [Abstract] [Full Text] [Related]

  • 23. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.
    Lichtman AH, Wiley JL, LaVecchia KL, Neviaser ST, Arthur DB, Wilson DM, Martin BR.
    Eur J Pharmacol; 1998 Sep 18; 357(2-3):139-48. PubMed ID: 9797029
    [Abstract] [Full Text] [Related]

  • 24. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
    Rawls SM, Schroeder JA, Ding Z, Rodriguez T, Zaveri N.
    Neuropeptides; 2007 Aug 18; 41(4):239-47. PubMed ID: 17512052
    [Abstract] [Full Text] [Related]

  • 25. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM, Wakley AA, Tsutsui KT, Laggart JD.
    J Pharmacol Exp Ther; 2012 Mar 18; 340(3):787-800. PubMed ID: 22182934
    [Abstract] [Full Text] [Related]

  • 26. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L, Spano S, Cossu G, Deiana S, Fadda P, Fratta W.
    Neuropharmacology; 2005 Jun 18; 48(8):1097-104. PubMed ID: 15910886
    [Abstract] [Full Text] [Related]

  • 27. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
    Martin RS, Secchi RL, Sung E, Lemaire M, Bonhaus DW, Hedley LR, Lowe DA.
    Psychopharmacology (Berl); 2003 Jan 18; 165(2):128-35. PubMed ID: 12404071
    [Abstract] [Full Text] [Related]

  • 28. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.
    Gessa GL, Casu MA, Carta G, Mascia MS.
    Eur J Pharmacol; 1998 Aug 21; 355(2-3):119-24. PubMed ID: 9760025
    [Abstract] [Full Text] [Related]

  • 29. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP, Kraichely DM, Wilken GH, Howlett AC.
    Biochem Pharmacol; 2000 Nov 01; 60(9):1315-23. PubMed ID: 11008125
    [Abstract] [Full Text] [Related]

  • 30. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB, Compton DR, Martin BR.
    J Pharmacol Exp Ther; 1998 Mar 01; 284(3):1209-17. PubMed ID: 9495885
    [Abstract] [Full Text] [Related]

  • 31. Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.
    Braida D, Pozzi M, Parolaro D, Sala M.
    Eur J Pharmacol; 2001 Feb 16; 413(2-3):227-34. PubMed ID: 11226397
    [Abstract] [Full Text] [Related]

  • 32. Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.
    Naderi N, Shafaghi B, Khodayar MJ, Zarindast MR.
    Eur J Pharmacol; 2005 May 09; 514(2-3):159-64. PubMed ID: 15910802
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological effects of cannabinoids on the reference and working memory functions in mice.
    Avdesh A, Hoe Y, Martins RN, Martin-Iverson MT.
    Psychopharmacology (Berl); 2013 Jan 09; 225(2):483-94. PubMed ID: 22903389
    [Abstract] [Full Text] [Related]

  • 34. Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.
    De Vry J, Rüdiger Jentzsch K.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):147-52. PubMed ID: 12464360
    [Abstract] [Full Text] [Related]

  • 35. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study.
    Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR.
    Pharmacol Biochem Behav; 2002 Dec 20; 74(1):31-40. PubMed ID: 12376150
    [Abstract] [Full Text] [Related]

  • 36. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
    Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA.
    Neuropharmacology; 1999 Apr 20; 38(4):533-41. PubMed ID: 10221757
    [Abstract] [Full Text] [Related]

  • 37. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH, Fisher J, Martin BR.
    Pharmacol Biochem Behav; 2001 Apr 20; 69(1-2):181-8. PubMed ID: 11420084
    [Abstract] [Full Text] [Related]

  • 38. Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
    Maneuf YP, Nash JE, Crossman AR, Brotchie JM.
    Eur J Pharmacol; 1996 Jul 18; 308(2):161-4. PubMed ID: 8840127
    [Abstract] [Full Text] [Related]

  • 39. Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands.
    Olivier B, Molewijk E, van Oorschot R, van der Heyden J, Ronken E, Mos J.
    Eur J Pharmacol; 1998 Oct 02; 358(2):117-28. PubMed ID: 9808260
    [Abstract] [Full Text] [Related]

  • 40. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M, Goldberg SR.
    Neuropsychopharmacology; 2005 Nov 02; 30(11):2035-45. PubMed ID: 15812567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.